Live feed
Filing
SC 13D/A
SC 13D/A0001144204-17-054325·Akari Therapeutics Plc
Schedule 13D ownership disclosure
Akari Therapeutics Plc
Security class unavailable · CUSIP: 00972G108
Event date: 2017-10-20
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 51.3000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001144204-17-054325
- Form type
- SC 13D/A
- Filer
- Akari Therapeutics Plc
- CIK
- CIK 1541157
- Filed
- Oct 26, 2017
- Reporting period
- Oct 20, 2017
- Description
- Schedule 13D beneficial ownership